Minor Components of Micropapillary and Solid Subtypes in Lung Adenocarcinoma are Predictors of Lymph Node Metastasis and Poor Prognosis

Clinical Impact of Minimal Micropapillary Pattern in Invasive Lung Adenocarcinoma

(2015) Geewon Lee et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Solid Component and Tumor Size Correlate With Prognosis of Stage IB Lung Adenocarcinoma

(2015) Songtao Xu et al.   ANNALS OF THORACIC SURGERY

Negative prognostic influence of micropapillary pattern in stage IA lung adenocarcinoma

(2015) Norifumi Tsubokawa et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification predicts occult lymph node metastasis in clinically mediastinal node-negative lung adenocarcinoma

(2015) Yi-Chen Yeh et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

Solid Predominant Histologic Subtype in Resected Stage I Lung Adenocarcinoma Is an Independent Predictor of Early, Extrathoracic, Multisite Recurrence and of Poor Postrecurrence Survival

(2015) Hideki Ujiie et al.   JOURNAL OF CLINICAL ONCOLOGY

The 2015 World Health Organization Classification of Lung Tumors

(2015) William D. Travis et al.   Journal of Thoracic Oncology

Relevance of the novel IASLC/ATS/ERS classification of lung adenocarcinoma in advanced disease

(2014) A. D. Campos-Parra et al.   EUROPEAN RESPIRATORY JOURNAL

Predictive Value of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification of Lung Adenocarcinoma in Tumor Recurrence and Patient Survival

(2014) Jung-Jyh Hung et al.   JOURNAL OF CLINICAL ONCOLOGY

A Comprehensive Investigation of Molecular Features and Prognosis of Lung Adenocarcinoma with Micropapillary Component

(2014) Yang Zhang et al.   Journal of Thoracic Oncology

The prognostic and predictive value of solid subtype in invasive lung adenocarcinoma

(2014) Yang Zhang et al.   Scientific Reports

Impact of Micropapillary Histologic Subtype in Selecting Limited Resection vs Lobectomy for Lung Adenocarcinoma of 2cm or Smaller

(2013) Jun-ichi Nitadori et al.   JNCI-Journal of the National Cancer Institute

Micropapillary and solid subtypes of invasive lung adenocarcinoma: Clinical predictors of histopathology and outcome

(2013) Min Jae Cha et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Correlation of Mutation Status and Survival with Predominant Histologic Subtype According to the New IASLC/ATS/ERS Lung Adenocarcinoma Classification in Stage III (N2) Patients

(2013) Prudence A. Russell et al.   Journal of Thoracic Oncology

The Novel Histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification System of Lung Adenocarcinoma Is a Stage-Independent Predictor of Survival

(2012) Arne Warth et al.   JOURNAL OF CLINICAL ONCOLOGY

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

(2011) William D. Travis et al.   Journal of Thoracic Oncology

Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases

(2011) Akihiko Yoshizawa et al.   MODERN PATHOLOGY

Survival without toxicity for cisplatin plus pemetrexed versus cisplatin plus gemcitabine in chemonaïve patients with advanced non-small cell lung cancer: A risk-benefit analysis of a large phase III study

(2009) Giorgio V. Scagliotti et al.   EUROPEAN JOURNAL OF CANCER

Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study

(2009) Tudor Ciuleanu et al.   LANCET

The Differential Efficacy of Pemetrexed According to NSCLC Histology: A Review of Two Phase III Studies

(2009) G. Scagliotti et al.   ONCOLOGIST

Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer

(2008) Giorgio Vittorio Scagliotti et al.   JOURNAL OF CLINICAL ONCOLOGY